MEDIKINET MR 20 MG MODIFIED-RELEASE CAPSULES

Kraj: Izrael

Język: angielski

Źródło: Ministry of Health

Składnik aktywny:

METHYLPHENIDATE HYDROCHLORIDE 20 MG

Dostępny od:

MEDILINE LTD.

Kod ATC:

N06BA04

Forma farmaceutyczna:

MODIFIED RELEASE CAPSULES

Droga podania:

PER OS

Wyprodukowano przez:

MEDICE ARZNEIMITTEL PUETTER GMBH & CO.KG, GERMANY

Grupa terapeutyczna:

METHYLPHENIDATE

Wskazania:

Medikinet Modified Release Capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient. Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.

Data autoryzacji:

2011-05-01